Global Atropine API 麻豆原创 Growth 2024-2030

Publication ID:

LPI05242148

Publication Date:

June 5, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Atropine is racemic hyoscyamine extracted from belladonna, datura and other plants of the same genus in the Solanaceae family. Its chemical formula is C17H23NO3. Its sulfate is a colorless crystal or white powder that is easily soluble in water. Atropine API is mainly used to prepare atropine drugs. Its main pharmacological effects are to block M choline receptors, relieve smooth muscle spasm (including relieving vasospasm and improving microvascular circulation), inhibit gland secretion, and relieve the inhibition of the vagus nerve on the heart. , speed up the heartbeat, dilate pupils, increase intraocular pressure, and excite the respiratory center. In addition, atropine can also excite or inhibit the central nervous system in a dose-dependent manner.
The global Atropine API market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淎tropine API Industry Forecast鈥� looks at past sales and reviews total world Atropine API sales in 2023, providing a comprehensive analysis by region and market sector of projected Atropine API sales for 2024 through 2030. With Atropine API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Atropine API industry.
This Insight Report provides a comprehensive analysis of the global Atropine API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Atropine API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Atropine API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Atropine API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Atropine API.
United States market for Atropine API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Atropine API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Atropine API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Atropine API players cover C2 Pharma, Katsura Chemical, HENAN PURUI, SAURAV CHEMICALS, ROLABO OUTSOURCING, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Atropine API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Purity 98%
Purity 99%
Purity 99.9%
Others
Segmentation by Application:
Gastrointestinal Drugs
Urinary System Drugs
Ophthalmic Drugs
Respiratory Medications
Cardiovascular Drugs
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
C2 Pharma
Katsura Chemical
HENAN PURUI
SAURAV CHEMICALS
ROLABO OUTSOURCING
Alchem International
Minsheng
RESONANCE LABORATORIES
Anant Labs
Key Questions Addressed in this Report
What is the 10-year outlook for the global Atropine API market?
What factors are driving Atropine API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Atropine API market opportunities vary by end market size?
How does Atropine API break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Atropine API Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Atropine API by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Atropine API by Country/Region, 2019, 2023 & 2030
2.2 Atropine API Segment by Type
2.2.1 Purity 98%
2.2.2 Purity 99%
2.2.3 Purity 99.9%
2.2.4 Others
2.3 Atropine API Sales by Type
2.3.1 Global Atropine API Sales 麻豆原创 Share by Type (2019-2024)
2.3.2 Global Atropine API Revenue and 麻豆原创 Share by Type (2019-2024)
2.3.3 Global Atropine API Sale Price by Type (2019-2024)
2.4 Atropine API Segment by Application
2.4.1 Gastrointestinal Drugs
2.4.2 Urinary System Drugs
2.4.3 Ophthalmic Drugs
2.4.4 Respiratory Medications
2.4.5 Cardiovascular Drugs
2.4.6 Others
2.5 Atropine API Sales by Application
2.5.1 Global Atropine API Sale 麻豆原创 Share by Application (2019-2024)
2.5.2 Global Atropine API Revenue and 麻豆原创 Share by Application (2019-2024)
2.5.3 Global Atropine API Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Atropine API Breakdown Data by Company
3.1.1 Global Atropine API Annual Sales by Company (2019-2024)
3.1.2 Global Atropine API Sales 麻豆原创 Share by Company (2019-2024)
3.2 Global Atropine API Annual Revenue by Company (2019-2024)
3.2.1 Global Atropine API Revenue by Company (2019-2024)
3.2.2 Global Atropine API Revenue 麻豆原创 Share by Company (2019-2024)
3.3 Global Atropine API Sale Price by Company
3.4 Key Manufacturers Atropine API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Atropine API Product Location Distribution
3.4.2 Players Atropine API Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Atropine API by Geographic Region
4.1 World Historic Atropine API 麻豆原创 Size by Geographic Region (2019-2024)
4.1.1 Global Atropine API Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Atropine API Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Atropine API 麻豆原创 Size by Country/Region (2019-2024)
4.2.1 Global Atropine API Annual Sales by Country/Region (2019-2024)
4.2.2 Global Atropine API Annual Revenue by Country/Region (2019-2024)
4.3 Americas Atropine API Sales Growth
4.4 APAC Atropine API Sales Growth
4.5 Europe Atropine API Sales Growth
4.6 Middle East & Africa Atropine API Sales Growth
5 Americas
5.1 Americas Atropine API Sales by Country
5.1.1 Americas Atropine API Sales by Country (2019-2024)
5.1.2 Americas Atropine API Revenue by Country (2019-2024)
5.2 Americas Atropine API Sales by Type (2019-2024)
5.3 Americas Atropine API Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Atropine API Sales by Region
6.1.1 APAC Atropine API Sales by Region (2019-2024)
6.1.2 APAC Atropine API Revenue by Region (2019-2024)
6.2 APAC Atropine API Sales by Type (2019-2024)
6.3 APAC Atropine API Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Atropine API by Country
7.1.1 Europe Atropine API Sales by Country (2019-2024)
7.1.2 Europe Atropine API Revenue by Country (2019-2024)
7.2 Europe Atropine API Sales by Type (2019-2024)
7.3 Europe Atropine API Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Atropine API by Country
8.1.1 Middle East & Africa Atropine API Sales by Country (2019-2024)
8.1.2 Middle East & Africa Atropine API Revenue by Country (2019-2024)
8.2 Middle East & Africa Atropine API Sales by Type (2019-2024)
8.3 Middle East & Africa Atropine API Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Atropine API
10.3 Manufacturing Process Analysis of Atropine API
10.4 Industry Chain Structure of Atropine API
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Atropine API Distributors
11.3 Atropine API Customer
12 World Forecast Review for Atropine API by Geographic Region
12.1 Global Atropine API 麻豆原创 Size Forecast by Region
12.1.1 Global Atropine API Forecast by Region (2025-2030)
12.1.2 Global Atropine API Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Atropine API Forecast by Type (2025-2030)
12.7 Global Atropine API Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 C2 Pharma
13.1.1 C2 Pharma Company Information
13.1.2 C2 Pharma Atropine API Product Portfolios and Specifications
13.1.3 C2 Pharma Atropine API Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 C2 Pharma Main Business Overview
13.1.5 C2 Pharma Latest Developments
13.2 Katsura Chemical
13.2.1 Katsura Chemical Company Information
13.2.2 Katsura Chemical Atropine API Product Portfolios and Specifications
13.2.3 Katsura Chemical Atropine API Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Katsura Chemical Main Business Overview
13.2.5 Katsura Chemical Latest Developments
13.3 HENAN PURUI
13.3.1 HENAN PURUI Company Information
13.3.2 HENAN PURUI Atropine API Product Portfolios and Specifications
13.3.3 HENAN PURUI Atropine API Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 HENAN PURUI Main Business Overview
13.3.5 HENAN PURUI Latest Developments
13.4 SAURAV CHEMICALS
13.4.1 SAURAV CHEMICALS Company Information
13.4.2 SAURAV CHEMICALS Atropine API Product Portfolios and Specifications
13.4.3 SAURAV CHEMICALS Atropine API Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 SAURAV CHEMICALS Main Business Overview
13.4.5 SAURAV CHEMICALS Latest Developments
13.5 ROLABO OUTSOURCING
13.5.1 ROLABO OUTSOURCING Company Information
13.5.2 ROLABO OUTSOURCING Atropine API Product Portfolios and Specifications
13.5.3 ROLABO OUTSOURCING Atropine API Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 ROLABO OUTSOURCING Main Business Overview
13.5.5 ROLABO OUTSOURCING Latest Developments
13.6 Alchem International
13.6.1 Alchem International Company Information
13.6.2 Alchem International Atropine API Product Portfolios and Specifications
13.6.3 Alchem International Atropine API Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Alchem International Main Business Overview
13.6.5 Alchem International Latest Developments
13.7 Minsheng
13.7.1 Minsheng Company Information
13.7.2 Minsheng Atropine API Product Portfolios and Specifications
13.7.3 Minsheng Atropine API Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Minsheng Main Business Overview
13.7.5 Minsheng Latest Developments
13.8 RESONANCE LABORATORIES
13.8.1 RESONANCE LABORATORIES Company Information
13.8.2 RESONANCE LABORATORIES Atropine API Product Portfolios and Specifications
13.8.3 RESONANCE LABORATORIES Atropine API Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 RESONANCE LABORATORIES Main Business Overview
13.8.5 RESONANCE LABORATORIES Latest Developments
13.9 Anant Labs
13.9.1 Anant Labs Company Information
13.9.2 Anant Labs Atropine API Product Portfolios and Specifications
13.9.3 Anant Labs Atropine API Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Anant Labs Main Business Overview
13.9.5 Anant Labs Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.